Author:
Smith Marie-Soleil R.,Saberi Sara,Ajaykumar Abhinav,Zhu Mayanne M. T.,Gadawski Izabelle,Sattha Beheroze,Maan Evelyn J.,Van Shalkwyk Julie,Elwood Chelsea,Pick Neora,Murray Melanie C. M.,Boucoiran Isabelle,Money Deborah M.,Côté Hélène C. F.
Abstract
AbstractUnderstanding the true burden of tobacco smoking on adverse pregnancy outcomes is critical in generating appropriate interventions to improve outcomes. Self-reporting of human behaviour that is associated with stigma is associated with underreporting in general and may bias the impact of smoking in studies; however, self-reporting is frequently the most practical method of gleaning this information. The objective of this study was to evaluate concordance between self-reported smoking and concentrations of plasma cotinine, a biomarker of smoking, among participants enrolled in two related HIV cohorts. A total of 100 pregnant women (76 living with HIV [LWH] and 24 negative controls) in their third trimester, and 100 men and non-pregnant women (43 LWH and 57 negative controls) were included. Among all participants, 43 pregnant women (49% LWH and 25% negative controls) and 50 men and non-pregnant women (58% LWH and 44% negative controls) were self-reported smokers. The odds of discordance between self-reported smoking and cotinine levels were not significantly different between self-reported smokers and non-smokers, nor between pregnant women and others, but were significantly increased, regardless of self-reported status, among people LWH compared to negative controls. The overall concordance between plasma cotinine and self-reported data among all participants was 94% with a sensitivity and specificity of 90% and 96%, respectively. Taken together, these data demonstrate that participant surveying in a non-judgemental context can lead to accurate and robust self-report smoking data among both persons LWH and not, including in the context of pregnancy.
Funder
Centre for Blood Research, University of British Columbia
Faculty of Medicine, University of British Columbia
Canadian Institutes of Health Research
Fonds de Recherche du Québec - Santé
Canadian HIV Trials Network, Canadian Institutes of Health Research
Canadian Foundation for AIDS Research
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. World Health Organization. World Health Statistics Data Visualizations Dashboard. Tobacco Smoking. https://apps.who.int/gho/data/node.sdg.3-a-viz?lang=en.
2. East, K. A., Reid, J. L. & Hammond, D. Smoking and vaping among Canadian youth and adults in 2017 and 2019. Tob Control 32, 259–262 (2021).
3. Cornelius, M. E., Loretan, C. G., Wang, T. W., Jamal, A. & Homa, D. M. Tobacco Product Use Among Adults: United States, 2020. MMWR Morb. Mortal Wkly. Rep. 71, 397–405 (2022).
4. Asfar, T. et al. National estimates of prevalence, time-trend, and correlates of smoking in US people living with HIV (NHANES 1999–2016). Nicotine Tob. Res. 23(8), 1308–1317 (2021).
5. Bekele, T. et al. Trends and correlates of cigarette smoking and its impacts on health-related quality of life among people living with HIV: Findings from the Ontario HIV Treatment Network Cohort Study, 2008–2014. AIDS Patient Care ST 31(2), 49–59 (2017).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献